Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00620009 · ClinicalTrials.gov registry record · NA
The Measurement of Empathy and Its Efficacy in Psychotherapy
A NA study of Psychotherapeutic Processes and Transference (Psychology), sponsored by University of Illinois at Chicago.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
- 1
- Study location
NCT00620009: Completed NA study of Psychotherapeutic Processes and Transference (Psychology), sponsored by University of Illinois at Chicago.
NCT00620009 is a NA study of Psychotherapeutic Processes and Transference (Psychology) that has completed, run by University of Illinois at Chicago. The registered enrollment target is 16 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00620009, a NA study of Psychotherapeutic Processes and Transference (Psychology), has completed, sponsored by University of Illinois at Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the research is to: 1) to test whether psychotherapy including immediate feedback of empathy data is more efficacious than therapy without such an exchange of data, 2) to measure the degree of accuracy of therapist's empathy and its relationship to the patient's estimate of the therapist's empathy.
Conditions Studied
Interventions
- BEHAVIORAL Empathy Feedback
Study Locations (1)
Illinois
- University of Illinois at Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2002-06 |
| Est. Completion | 2007-06 |
| Phase | NA |
What the finished NCT00620009 record still lists
NCT00620009 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Psychotherapeutic Processes appearing as the primary indexed condition, and to 1 intervention - of which Empathy Feedback is the first listed.
NCT00620009 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT00620009 about?
NCT00620009 is a clinical study titled "The Measurement of Empathy and Its Efficacy in Psychotherapy". The purpose of the research is to: 1) to test whether psychotherapy including immediate feedback of empathy data is more efficacious than therapy without such an exchange of data, 2) to measure the degree of accuracy of therapist's empathy and its relationship to the patient's estimate of the therap...
What is the current status of trial NCT00620009?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2002-06. Estimated completion is 2007-06.
What conditions does trial NCT00620009 study?
This clinical trial studies the following conditions: Psychotherapeutic Processes, Transference (Psychology).
What interventions are being tested in trial NCT00620009?
The interventions under investigation include: Empathy Feedback (BEHAVIORAL).
Who is sponsoring clinical trial NCT00620009?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00620009 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00620009's enrollment target sits among peer trials
16 1871st of 2000 higher than 120 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia